1,8,10,17-TETRAAZAPENTACYCLO-[8.8.1.1(8,17).0(2,7).0(11,16)]-ICOSANE
Compound with spectra: 1 NMR
![1,8,10,17-TETRAAZAPENTACYCLO-[8.8.1.1(8,17).0(2,7).0(11,16)]-ICOSANE](/api/compound/K35VNNAX3xb.png?ph=true&h=300&w=458 "1,8,10,17-TETRAAZAPENTACYCLO-[8.8.1.1(8,17).0(2,7).0(11,16)]-ICOSANE")
| SpectraBase Compound ID | K35VNNAX3xb |
|---|---|
| InChI | InChI=1S/C16H28N4/c1-2-6-14-13(5-1)17-9-19-11-18(14)12-20(10-17)16-8-4-3-7-15(16)19/h13-16H,1-12H2/t13-,14-,15-,16-/m1/s1 |
| InChIKey | FIDIPBYMFPVTCL-KLHDSHLOSA-N |
| Mol Weight | 276.43 g/mol |
| Molecular Formula | C16H28N4 |
| Exact Mass | 276.231397 g/mol |
| Enantiomer InChIKey | FIDIPBYMFPVTCL-VGWMRTNUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1,5-dicyclohexyltetrahydro-1,3,5-triazine-2(1H)-thione
(R,R)-Benzyldimethyl(N,N',N''-trimethylcyclohexan-1,2-diamino-N-methyl)silane
5-cyclohexyl-1-(2-phenylethyl)tetrahydro-1,3,5-triazine-2(1H)-thione
1,3,5-Triazine-2(1H)-thione, 5-cyclopentyltetrahydro-1-(2-phenylethyl)-
METHYL-4-(2-[3-[(3-[2-[4-(METHOXYCARBONYL)-PHENYL]-1-DIAZENYL]-1,3-DIAZEPAN-1-YL)-METHYL]-1,3-DIAZEPAN-1-YL]-1-DIAZENYL)-BENZOATE
1-[2-(ORTHO-BROMOPHENYL)-1-DIAZENYL]-3-(3-[2-(ORTHO-BROMOPHENYL)-1-DIAZENYL]-HEXAHYDRO-1-PYRIMIDINYLMETHYL)-HEXAHYDROPYRIMIDINE
3,8-DI-[2-(PARA-METHOXYCARBONYLPHENYL)-1-AZENYL]-1,3,6,8-TETRAAZABICYCLO-[4.4.1]-UNDECANE
CIS-1,3,7-TRIMETHYL-CIS-1,3,5,7-TETRAAZADECALIN
N,N''-(1R,2R)-1,2-CYCLOHEXANEDIYL-BIS-[N''-TRICYCLO-[3.3.1.1(3,7)]-DEC-1-1-YLUREA]
n,n'-Dichloroformyl-2,2'-bipyrrolidine
| Title | Journal or Book | Year |
|---|---|---|
| A series of 1-[2-aryl-1-diazenyl]-3-({3-[2-aryl-1-diazenyl]perhydrobenzo[d]imidazol-1-yl}methyl)perhydrobenzo[d]imidazoles. Synthesis and characterization | Journal of Heterocyclic Chemistry | 2006 |